171 related articles for article (PubMed ID: 25318615)
1. Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.
Ahn SB; Mohamedali A; Anand S; Cheruku HR; Birch D; Sowmya G; Cantor D; Ranganathan S; Inglis DW; Frank R; Agrez M; Nice EC; Baker MS
J Proteome Res; 2014 Dec; 13(12):5956-64. PubMed ID: 25318615
[TBL] [Abstract][Full Text] [Related]
2. A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking.
Sowmya G; Khan JM; Anand S; Ahn SB; Baker MS; Ranganathan S
J Struct Biol; 2014 Mar; 185(3):327-35. PubMed ID: 24423664
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
Saldanha RG; Molloy MP; Bdeir K; Cines DB; Song X; Uitto PM; Weinreb PH; Violette SM; Baker MS
J Proteome Res; 2007 Mar; 6(3):1016-28. PubMed ID: 17330942
[TBL] [Abstract][Full Text] [Related]
4. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
Tang CH; Hill ML; Brumwell AN; Chapman HA; Wei Y
J Cell Sci; 2008 Nov; 121(Pt 22):3747-56. PubMed ID: 18940913
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
7. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
Ahmed N; Pansino F; Baker M; Rice G; Quinn M
J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
[TBL] [Abstract][Full Text] [Related]
8. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ6 sets the stage for colorectal cancer metastasis.
Cantor DI; Cheruku HR; Nice EC; Baker MS
Cancer Metastasis Rev; 2015 Dec; 34(4):715-34. PubMed ID: 26337740
[TBL] [Abstract][Full Text] [Related]
10. Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.
Duque H; LaRocco M; Golde WT; Baxt B
J Virol; 2004 Sep; 78(18):9773-81. PubMed ID: 15331710
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
12. Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.
Morgan MR; Jazayeri M; Ramsay AG; Thomas GJ; Boulanger MJ; Hart IR; Marshall JF
Oncogene; 2011 Mar; 30(12):1422-35. PubMed ID: 21132011
[TBL] [Abstract][Full Text] [Related]
13. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
14. The effects of amino-acid mutations on specific interactions between urokinase-type plasminogen activator and its receptor: Ab initio molecular orbital calculations.
Tsuji S; Kasumi T; Nagase K; Yoshikawa E; Kobayashi H; Kurita N
J Mol Graph Model; 2011 Aug; 29(8):975-84. PubMed ID: 21605990
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of αvβ6 integrin alters the colorectal cancer cell proteome in favor of elevated proliferation and a switching in cellular adhesion that increases invasion.
Cantor D; Slapetova I; Kan A; McQuade LR; Baker MS
J Proteome Res; 2013 Jun; 12(6):2477-90. PubMed ID: 23668677
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
[TBL] [Abstract][Full Text] [Related]
19. RhoB regulates uPAR signalling.
Alfano D; Ragno P; Stoppelli MP; Ridley AJ
J Cell Sci; 2012 May; 125(Pt 10):2369-80. PubMed ID: 22366462
[TBL] [Abstract][Full Text] [Related]
20. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
Nip J; Rabbani SA; Shibata HR; Brodt P
J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
